Sudden cardiac death: epidemiology, transient risk, and intervention assessment.
about
Sudden cardiac death athletes: a systematic reviewEpidemiology and genetics of ventricular fibrillation during acute myocardial infarctionCardioversion: Past, Present, and FuturePhase-rectified signal averaging for the detection of quasi-periodicities and the prediction of cardiovascular risk.Drug- and non-drug-associated QT interval prolongation.Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts.Usefulness of nonlinear analysis of ECG signals for prediction of inducibility of sustained ventricular tachycardia by programmed ventricular stimulation in patients with complex spontaneous ventricular arrhythmias.Happiness and stress alter susceptibility to cardiac events in Long QT SyndromeSmoking, smoking cessation, and risk of sudden cardiac death in women.HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failureElevated plasma free fatty acids are associated with sudden death: a prospective community-based evaluation at the time of cardiac arrestN-3 polyunsaturated fatty acids and cardiac mortality.Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluationBeta-blockers and amiodarone for the primary prevention of sudden cardiac death.Failure in short-term prediction of ventricular tachycardia and ventricular fibrillation from continuous electrocardiogram in intensive care unit patients.Can sudden cardiac death be predicted from the T wave of the ECG? A critical examination of T wave alternans and QT interval dispersion.Premature Ventricular Contractions and Non-sustained Ventricular Tachycardia: Association with Sudden Cardiac Death, Risk Stratification, and Management StrategiesDeletion of FoxO1 leads to shortening of QRS by increasing Na(+) channel activity through enhanced expression of both cardiac NaV1.5 and β3 subunitM3 subtype of muscarinic acetylcholine receptor promotes cardioprotection via the suppression of miR-376b-5p.Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults.Aborted sudden cardiac death: a clinical perspectiveCardiac mitochondria and arrhythmias.Alcohol ablation at the posterior papillary muscle prevents ventricular fibrillation in swine without affecting mitral valve function.Are drugs and catheter ablation effective for treating ventricular arrhythmias in populations that cannot afford implantable cardioverter defibrillators?Amiodarone in the new AHA guidelines for ventricular tachyarrhythmias.T-wave alternans and arrhythmia risk stratification.T-wave alternans for risk stratification and prevention of sudden cardiac death.A computer case definition for sudden cardiac death.Strategies for the prevention and treatment of sudden cardiac death.Characteristics of sudden arrhythmic death in a diverse, urban communityPanic Disorder and Chest Pain: Mechanisms, Morbidity, and Management.Sudden cardiac death in patients with diabetes.Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotypeTrends in sudden cardiac death and its risk factors in Japan from 1981 to 2005: the Circulatory Risk in Communities Study (CIRCS).Weather and triggering of ventricular arrhythmias in patients with implantable cardioverter-defibrillators.Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome.A common variant in SLC8A1 is associated with the duration of the electrocardiographic QT interval.Associations between the ankle-brachial index and cardiovascular and all-cause mortality are similar in individuals without and with type 2 diabetes: nineteen-year follow-up of a population-based cohort studyUse of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
P2860
Q21198776-0980967D-C616-488C-A8FC-BDCB6E41C0BEQ28072276-43096C00-A65F-4F64-BC1D-7F39DB6C4EBEQ28972392-A7582DE7-BFE8-4F72-8305-70F94C20BE53Q30319853-6004D979-8BD8-454C-8664-E9E76446CC27Q30474909-33B97270-CD11-4ABF-8049-BED9C6381EADQ33152121-B36061FB-0D4D-4F69-8D8C-18D0675A610AQ33156551-D8E3BE6A-5E47-4556-9B7D-B7FFE966A5C2Q33157376-339BBFCC-EC2E-4D0F-844B-FFEE41C39974Q33630927-01DA9871-131A-49D9-931D-16A0E176AC8AQ33815633-756BCBFA-B557-4B65-BF15-B44DB68860CFQ33828109-E138DC55-EEEC-4DA5-930E-A482F68D1141Q33835566-08FF19BD-8C62-48B5-ACD9-1C5E58B70F8DQ33930781-5886C857-D9E3-4AF9-A35D-7E95505876E7Q34000106-31866FCE-D650-4580-A287-194077EA2C3EQ34027338-93B736A6-423F-45CB-9E81-1BA731BB20F8Q34040045-F8ADE5E9-54FB-4503-99CE-CA77D2A63641Q34057104-EF5A0020-495B-4ED9-AF75-9B4AD141B2E7Q34070684-73350E87-327A-42FC-8B13-A20B675FD503Q34154347-C8B70AF5-336E-4098-AA81-5CC9CBCD6090Q34187234-0E3E15A3-09A9-47C8-BA70-1E3A66A08CADQ34202997-C537028C-E83A-46A4-8AB5-85321A488809Q34262959-BC756E57-5111-4435-B2FA-94FB33B7BE9CQ34307966-50B1D4E2-ECEC-46B5-A5D3-C8527779C56AQ34334858-785AA8BD-918E-4244-8A2C-F8B022A1DECDQ34401823-D6BFD3DB-EE4B-43E5-9BD3-1B310BB69A89Q34417301-9A020B7D-9A92-4781-B8F1-57F995FCD7AFQ34423811-D4CE1D7C-8A3C-4B65-9705-83A419198C19Q35198959-35EA6067-C2DC-40E0-9DE7-78C269D65703Q35236075-C8E00033-2E21-4CE3-8AEA-B6F35C5BF3CCQ35560103-B2A305E6-3D83-43DE-A25A-743AEFD26CF2Q35621770-260E7CFE-4C5A-48CA-8832-15D5675DB172Q35667037-64CCEA33-944F-49E2-A276-1199343FE8E1Q35767296-48502C95-2DFB-48C5-88CE-B332C414C56AQ35768561-7CED000C-F5A8-42B7-888E-AC6F97218A9EQ35852042-7B388AAE-B93F-475E-BE70-E381E6BFD98AQ35854645-2EA03D53-B2EF-4626-BE72-C1847C3765BBQ35996165-68BEA5E5-F0D4-49FA-AEDB-4B9873053305Q36096065-C2212A2B-D42F-4E18-839D-078A5F208C3EQ36109109-E4187575-E5B8-4221-B093-D9ECE65286E2Q36125470-153A4DF0-69E4-4BE7-89A1-EB9A86C52385
P2860
Sudden cardiac death: epidemiology, transient risk, and intervention assessment.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Sudden cardiac death: epidemiology, transient risk, and intervention assessment.
@en
type
label
Sudden cardiac death: epidemiology, transient risk, and intervention assessment.
@en
prefLabel
Sudden cardiac death: epidemiology, transient risk, and intervention assessment.
@en
P2093
P1476
Sudden cardiac death: epidemiology, transient risk, and intervention assessment.
@en
P2093
Castellanos A
Kessler KM
Myerburg RJ
P304
P356
10.7326/0003-4819-119-12-199312150-00006
P407
P577
1993-12-01T00:00:00Z